Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles-Reference-Cited by-同舟云学术

Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles

Published:2007-09 Issue:1-3 Volume:74 Page:119-129
ISSN:0361-9230
Container-title:Brain Research Bulletin
language:en
Short-container-title:Brain Research Bulletin

Author:

Ioja Enikő,Tourwé Dirk,Kertész István,Tóth Géza,Borsodi Anna,Benyhe Sándor

Publisher

Elsevier BV

Subject

General Neuroscience

Reference60 articles.

1. Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice;Abdelhamid;J. Pharmacol. Exp. Ther.,1991

2. Conformational analysis of potent and very selective delta opioid dipeptide antagonists;Amodeo;FEBS Lett.,1995

3. Immunosuppressive effect of delta-opioid receptor antagonist on xenogeneic mixed lymphocyte reaction;Arakawa;Transplant. Proc.,1992

4. A superactive antinociceptive pentapeptide, (d-Met2,Pro5)-enkephalinamide;Bajusz;FEBS Lett.,1977

5. Met5-enkephalin-Arg6-Phe7, an endogenous neuropeptide, binds to multiple opioid and nonopioid sites in rat brain;Benyhe;J. Neurosci. Res.,1997

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of Novel µ-Opioid Receptor Inverse Agonist from a Combinatorial Library of Tetrapeptides through Structure-Based Virtual Screening;Molecules;2019-10-27

2. Opioid Receptor Activity and Analgesic Potency of DPDPE Peptide Analogues Containing a Xylene Bridge;ACS Medicinal Chemistry Letters;2017-03-16

3. Evaluation of the analgesic effect of 4-anilidopiperidine scaffold containing ureas and carbamates;Journal of Enzyme Inhibition and Medicinal Chemistry;2016-04-11

4. Micromolar concentrations of rimonabant directly inhibits delta opioid receptor specific ligand binding and agonist-induced G-protein activity;Neurochemistry International;2014-02

5. In vitro binding affinities of a series of flavonoids for μ-opioid receptors. Antinociceptive effect of the synthetic flavonoid 3,3-dibromoflavanone in mice;Neuropharmacology;2013-09